Literature DB >> 16952280

Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis.

Douglas A Corley1, Ai Kubo.   

Abstract

BACKGROUND: Gastroesophageal reflux disease (GERD) is a common cause of morbidity and health-care utilization in many countries. Obesity is a potentially modifiable risk factor, but existing studies have conflicting results, possibly due to differences in study design, definitions, or populations.
METHODS: We performed a systematic review and meta-analysis of studies identified using MEDLINE, the Web of Science electronic database, manual literature review, and a review of expert bibliographies. Studies were included if they: (1) evaluated obesity, body mass index (BMI), or another measure of body size; (2) included data on reflux symptoms, esophagitis, or a GERD-related hospitalization; and (3) reported a relative risk or odds ratio (OR) with confidence intervals or provided sufficient data to permit their calculation.
RESULTS: We identified 20 studies that included 18,346 patients with GERD. Studies from the United States demonstrated an association between increasing BMI and the presence of GERD (95% confidence interval [CI]= 1.36-1.80, overweight, OR = 1.57, P value homogeneity = 0.51, 95% CI = 1.89-2.45, obese, OR = 2.15, P= 0.10). Studies from Europe provided heterogeneous results despite stratification for several factors; individual studies demonstrated both positive associations and no association.
CONCLUSIONS: This analysis demonstrates a positive association between increasing BMI and the presence of GERD within the United States; this relationship became apparent only after stratification by country and level of BMI. These results support the evaluation of weight reduction as a potential therapy for GERD. Further studies are needed to evaluate potential mechanisms and any differences in this relationship among different study populations.

Entities:  

Mesh:

Year:  2006        PMID: 16952280     DOI: 10.1111/j.1572-0241.2006.00849.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  97 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

2.  Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link?

Authors:  Douglas A Corley
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

Review 3.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Anamay N Sharma; Mohammad Hassan Murad; Navtej S Buttar; Hashem B El-Serag; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-22       Impact factor: 11.382

4.  Functional Gastrointestinal Disorders in Obese Patients. The Importance of the Enrollment Source.

Authors:  Michel Bouchoucha; Marinos Fysekidis; Chantal Julia; Gheorghe Airinei; Jean-Marc Catheline; Gérard Reach; Robert Benamouzig
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

Review 5.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

6.  Risk factors for erosive esophagitis: a cross-sectional study of a large number of Japanese males.

Authors:  Toshiaki Gunji; Hajime Sato; Kimiko Iijima; Kazutoshi Fujibayashi; Mitsue Okumura; Noriko Sasabe; Akio Urabe; Nobuyuki Matsuhashi
Journal:  J Gastroenterol       Date:  2011-01-13       Impact factor: 7.527

7.  Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial.

Authors:  Mandeep Singh; Jaehoon Lee; Neil Gupta; Srinivas Gaddam; Bryan K Smith; Sachin B Wani; Debra K Sullivan; Amit Rastogi; Ajay Bansal; Joseph E Donnelly; Prateek Sharma
Journal:  Obesity (Silver Spring)       Date:  2013-02       Impact factor: 5.002

8.  Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett's esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population.

Authors:  Stefano Realdon; Alessandro Antonello; Diletta Arcidiacono; Elisa Dassie; Francesco Cavallin; Matteo Fassan; Maria Teresa Nardi; Alfredo Alberti; Massimo Rugge; Giorgio Battaglia
Journal:  Eur J Nutr       Date:  2015-07-10       Impact factor: 5.614

9.  Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms.

Authors:  Shahin Ayazi; Jeffrey A Hagen; Linda S Chan; Steven R DeMeester; Molly W Lin; Ali Ayazi; Jessica M Leers; Arzu Oezcelik; Farzaneh Banki; John C Lipham; Tom R DeMeester; Peter F Crookes
Journal:  J Gastrointest Surg       Date:  2009-05-28       Impact factor: 3.452

10.  The prevalence of gastrointestinal symptoms in patients with non-insulin dependent diabetes mellitus.

Authors:  Jung-Hwan Oh; Myung-Gyu Choi; Moo-Il Kang; Kang-Moon Lee; Jin Il Kim; Byung-Wook Kim; Dong-Soo Lee; Sung-Soo Kim; Hwang Choi; Sok-Won Han; Kyu-Yong Choi; Ho-Young Son; In-Sik Chung
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.